Market Place
Sourcing Support
All News #Library
Biotech
Abzena Tops Frost & Sullivan`s ADC CDMO Radar Report
17 Mar 2026 //
PR NEWSWIRE
Orion, Abzena Secure Exclusive Commercial License For Antibody
24 Oct 2025 //
PRESS RELEASE
Abzena Enhances AbZelectPRO™ with New GS Knockout Platforms
15 Sep 2025 //
PR NEWSWIRE
Abzena Forms Scientific Advisory Board for Innovation Strategy
15 May 2025 //
CONTRACTPHARMA
Abzena Appoints Taylor Boyd as CBO
26 Feb 2025 //
PR NEWSWIRE
Abzena Expands GMP Cell-Based Potency Testing in US & UK
19 Nov 2024 //
PR NEWSWIRE
Abzena Expands Microbiology Lab for Biologic Manufacturing
30 Oct 2024 //
PR NEWSWIRE
AbZelectPRO Enables Faster Research Cell Bank Production
26 Sep 2024 //
PR NEWSWIRE
Abzena Supplies Clinical Trial Material For Angiex`s AGX101 Study
08 Aug 2024 //
PR NEWSWIRE
Abzena Launches LabZient™, an Analytical Platform
07 Feb 2024 //
PR NEWSWIRE
Abzena partners with FDA on publication demonstrating benefits of MAPPs assay
19 Dec 2023 //
PR NEWSWIRE
Abzena Names Thomas Castellano Chief Financial Officer
06 Jun 2023 //
CONTRACT PHARMA
Abzena Taps Sean O’Brien for Senior VP, Site Head at San Diego Facility
03 Apr 2023 //
PRESS RELEASE
Abzena Reinforces Senior Leadership Team
14 Mar 2023 //
CONTRACT PHARMA
In apparent transition, Abzena lays off 66 in San Diego
25 Jan 2023 //
FIERCE PHARMA
Abzena Names Matthew Stober CEO
05 Jan 2023 //
CONTRACT PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.